Sources: Lycia Therapeutics: upsized IPO pricing; Dubai Investments: DIP Holding intention to float

Lycia: base issue and optional shares

Million shares; priced October 22, 2026

08.8217.6417.64Base new shares2.65Additional option
Option exercise is unverified; October 26 settlement was expected after cutoff. [1]

Sources: [1] Lycia Therapeutics: upsized IPO pricing · October 22, 2026; expected October 26 settlement

This analysis examines the implications of the week’s verified reporting, the assumptions behind the financial measures and the developments to monitor next.

ORIGINAL ANALYSIS · MEMBER ACCESS

Go beyond the headline.

Premium articles cost $2 per article. Read this analysis with a one-time purchase, or explore every premium web article with Digital.

Library Pass includes every article and newspaper PDF for $299/year. Compare access →

A member account is required before payment. Already purchased? Sign in.